Cardiovascular Devices Market By Product (Cardiovascular Monitoring and Diagnostic Devices, Coronary Stents, Pacemakers, Defibrillators, Interventional Cardiac Devices, Heart Valves, Cardiac Ablation Catheters, Ventricular Assist Devices), By Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Rheumatic Heart Disease, Cerebrovascular Heart Disease), By End User (Hospitals, Ambulatory Surgery Centers, Diagnostic Clinics), and By Region - Trends, Analysis and Forecast till 2034

Increased occurrence of cardiovascular diseases

One of the main factors propelling the global market for cardiovascular devices is the increasing prevalence of chronic cardiovascular disorders across the globe. According to the Centers for Disease Control and Prevention, cardiovascular disease is the leading cause of death in the US for both men and women, as well as for people from the majority of racial and ethnic groups. In the US, cardiovascular disease takes one life every 33 seconds. About 695,000 Americans lost their lives to cardiovascular disease in 2021, making about 1 in 5 fatalities.

The leading causes of cardiovascular diseases are rising salt intake, rising tobacco usage, rising smoking rates, and rising alcohol consumption. Cardiovascular diseases can be effectively treated if they are detected early. Therefore, it is expected that the global market for cardiovascular devices will rise as a result of the increasing requirement for early detection of cardiovascular illnesses. Furthermore, there is a concerning increase in the number of obese individuals and the elderly population, coupled with a decrease in physical activity. These factors increase the risk of cardiovascular disorders and are expected to drive the global market for cardiovascular devices.

Technological Progress

The technology utilized to create cardiovascular devices and the uses for these devices has advanced significantly throughout the last ten years. Because of this, a greater number of patients are undergoing therapy with cardiovascular devices, leading to good treatment and monitoring results. Patients with advanced stages of cardiovascular disease often require improved cardiovascular devices for diagnosis and therapy. This is a result of heightened knowledge and demand for medical equipment like coronary stents that have better safety features. The patient requires devices that don't cause unfavorable side effects, such as infections, which can be caused by bare-metal stents among other types of stents.

One such development that substantially aids cardiology is artificial intelligence in cardiovascular devices, which is more skilled at tracking specific cardiac problems. For example, the US FDA authorized Medtronic's use of two AccuRhythm AI algorithms in July 2021, improving the informational accuracy that physicians receive to assist in identifying and treating abnormal heart rhythms.